Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer

NCT03007979 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Carcinoma
Cancer of Breast
Malignant Tumor of Breast

Interventions

DRUG: Palbociclib
DRUG: Letrozole
DRUG: Fulvestrant
PROCEDURE: Optional research biopsy
DRUG: Goserelin
PROCEDURE: Research blood draw
PROCEDURE: Circulating tumor cell blood draw
PROCEDURE: Tumor biopsy (optional)

Sponsor

Washington University School of Medicine

Collaborators

[object Object]